Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis

J Turner, JB Torrelles - Pathogens and disease, 2018 - academic.oup.com
Abstract Mannose-capped lipoarabinomannan (ManLAM), present in all members of the
Mycobacterium tuberculosis complex and in other pathogenic Mycobacterium spp, is a high …

Underestimated Manipulative Roles of Mycobacterium tuberculosis Cell Envelope Glycolipids During Infection

A Garcia-Vilanova, J Chan, JB Torrelles - Frontiers in immunology, 2019 - frontiersin.org
The Mycobacterium tuberculosis cell envelope has been evolving over time to make the
bacterium transmissible and adaptable to the human host. In this context, the M. tuberculosis …

Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection

K Dijkman, N Aguilo, C Boot, SO Hofman… - Cell Reports …, 2021 - cell.com
To fight tuberculosis, better vaccination strategies are needed. Live attenuated
Mycobacterium tuberculosis-derived vaccine, MTBVAC, is a promising candidate in the …

Tuberculosis in the elderly: Why inflammation matters

TJ Piergallini, J Turner - Experimental gerontology, 2018 - Elsevier
Growing old is associated with an increase in the basal inflammatory state of an individual
and susceptibility to many diseases, including infectious diseases. Evidence is growing to …

Mycobacteriophages as potential therapeutic agents against drug-resistant tuberculosis

A Allué-Guardia, R Saranathan, J Chan… - International journal of …, 2021 - mdpi.com
The current emergence of multi-, extensively-, extremely-, and total-drug resistant strains of
Mycobacterium tuberculosis poses a major health, social, and economic threat, and stresses …

BCG vaccination strategies against tuberculosis: updates and perspectives

M Qu, X Zhou, H Li - Human Vaccines & Immunotherapeutics, 2021 - Taylor & Francis
ABSTRACT Bacillus Calmette-Guérin (BCG) is the only licensed vaccine against
tuberculosis (TB). However, BCG has variable efficacy and cannot completely prevent TB …

Tweaking host immune responses for novel therapeutic approaches against Mycobacterium tuberculosis

A Roy, PK Agnivesh, S Sau, S Kumar, NP Kalia - Drug Discovery Today, 2023 - Elsevier
In TB, combat between the human host and Mycobacterium tuberculosis involves intricate
interactions with immune cells. M. tuberculosis has evolved a complex evasion system to …

Immune correlates of protection as a game changer in tuberculosis vaccine development

J Wang, XY Fan, Z Hu - npj Vaccines, 2024 - nature.com
The absence of validated correlates of protection (CoPs) hampers the rational design and
clinical development of new tuberculosis vaccines. In this review, we provide an overview of …

The Lung Mucosa Environment in the Elderly Increases Host Susceptibility to Mycobacterium tuberculosis Infection

JI Moliva, MA Duncan, A Olmo-Fontánez… - The Journal of …, 2019 - academic.oup.com
As we age, there is an increased risk for the development of tuberculosis (TB) caused by
Mycobacterium tuberculosis (Mtb) infection. Few studies consider that age-associated …

[HTML][HTML] Human alveolar lining fluid from the elderly promotes Mycobacterium tuberculosis intracellular growth and translocation into the cytosol of alveolar epithelial …

AM Olmo-Fontánez, JM Scordo, A Schami… - Mucosal …, 2024 - Elsevier
The elderly population is highly susceptible to developing respiratory diseases, including
tuberculosis, a devastating disease caused by the airborne pathogen Mycobacterium …